mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.03 |
mRNA |
BIX02189 |
GDSC1000 |
pan-cancer |
AAC |
-0.072 |
0.03 |
mRNA |
SNX-2112 |
GDSC1000 |
pan-cancer |
AAC |
-0.068 |
0.03 |
mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.03 |
mRNA |
VX-11e |
GDSC1000 |
pan-cancer |
AAC |
-0.075 |
0.03 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.03 |
mRNA |
BRD-K97651142 |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.03 |
mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.03 |
mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.03 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.03 |